Skip to main navigation Skip to search Skip to main content

Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

BACKGROUND: A key focus in cancer research is the discovery of biomarkers that accurately diagnose early lesions in non-invasive tissues. Several studies have identified malignancy-associated DNA methylation changes in blood, yet no general cancer biomarker has been identified to date. Here, we explore the potential of blood DNA methylation as a biomarker of pan-cancer (cancer of multiple different origins) in 41 female cancer discordant monozygotic (MZ) twin-pairs sampled before or after diagnosis using the Illumina HumanMethylation450 BeadChip.
Original languageEnglish
Pages (from-to)1-16
JournalClinical epigenetics
Volume8
Issue number7
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cohort Studies

  • Netherlands Twin Register (NTR)

Fingerprint

Dive into the research topics of 'Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs'. Together they form a unique fingerprint.

Cite this